Literature DB >> 10202268

Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project.

N Andreasen1, K Blennow, C Sjödin, B Winblad, K Svärdsudd.   

Abstract

In the Piteå River Valley all persons with memory impairment that interferes with normal life are referred to one hospital department for clinical workup and diagnosis. 619 patients were assessed in the department during the years 1990-1995. Of these, 36.9% had Alzheimer's disease (AD), 30.4% had vascular dementia (VaD), 3.0% had a mixed AD/VaD, 3.2% had frontotemporal dementia and 5.3% had other forms of dementia. Another 7% had memory impairment but no dementia. The overall mean annual incidence rate of clinically relevant dementia was 295/100,000 persons at risk and the mean prevalence rate was 755/100,000 persons. For persons 65 years and older the incidence and prevalence rates were 840 and 2,150/100,000 persons, respectively. This means that annually, approximately 300 persons/100,000 population over the age of 40 need medical attention or social services.

Entities:  

Mesh:

Year:  1999        PMID: 10202268     DOI: 10.1159/000026206

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  14 in total

1.  A Swedish programme for dementia diagnostics in primary healthcare.

Authors:  Erik Jedenius; Anders Wimo; Jan Strömqvist; Niels Andreasen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

2.  Data requirements in a model of the natural history of Alzheimer's disease.

Authors:  T J Chaussalet; W A Thompson
Journal:  Health Care Manag Sci       Date:  2001-02

3.  [Presenile dementia in memory clinics--incidence rates and clinical features].

Authors:  H Bickel; K Bürger; H Hampel; Y Schreiber; A Sonntag; B Wiegele; H Förstl; A Kurz
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

4.  Rate of early onset Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Xi-Chen Zhu; Lan Tan; Hui-Fu Wang; Teng Jiang; Lei Cao; Chong Wang; Jun Wang; Chen-Chen Tan; Xiang-Fei Meng; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2015-03

5.  Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.

Authors:  T Darreh-Shori; L Meurling; T Pettersson; K Hugosson; E Hellström-Lindahl; N Andreasen; L Minthon; A Nordberg
Journal:  J Neural Transm (Vienna)       Date:  2006-08-01       Impact factor: 3.575

6.  The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study.

Authors:  Marte Kvello-Alme; Geir Bråthen; Linda R White; Sigrid Botne Sando
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds.

Authors:  T B Gislason; M Sjögren; L Larsson; I Skoog
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

8.  Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.

Authors:  Patrick G Kehoe; Hagit Katzov; Niels Andreasen; Maragaret Gatz; Gordon K Wilcock; Nigel J Cairns; Juni Palmgren; Ulf de Faire; Anthony J Brookes; Nancy L Pedersen; Kaj Blennow; Jonathan A Prince
Journal:  Hum Genet       Date:  2004-02-17       Impact factor: 4.132

9.  Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy.

Authors:  Livia Bernardi; Francesca Frangipane; Nicoletta Smirne; Rosanna Colao; Gianfranco Puccio; Sabrina Am Curcio; Maria Mirabelli; Raffaele Maletta; Maria Anfossi; Maura Gallo; Silvana Geracitano; Maria Elena Conidi; Raffale Di Lorenzo; Alessandra Clodomiro; Chiara Cupidi; Sandra Marzano; Francesco Comito; Vincenzo Valenti; Maria Angela Zirilli; Mahdi Ghani; Zhengrui Xi; Christine Sato; Danielle Moreno; Annelisa Borelli; Rosa Anna Leone; Peter St George-Hyslop; Ekaterina Rogaeva; Amalia C Bruni
Journal:  Neurobiol Aging       Date:  2012-07-20       Impact factor: 4.673

10.  Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.

Authors:  E R Padayachee; H Zetterberg; E Portelius; J Borén; J L Molinuevo; N Andreasen; R Cukalevski; S Linse; K Blennow; U Andreasson
Journal:  Brain Res       Date:  2016-09-23       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.